DTIL - Company ID 0001357874
The table below shows PRECISION BIOSCIENCES INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$11.94M | -$19.05M | -$18.98M | -$31.46M | -$28.87M | $68.07M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$114.00K | -$314.00K | -$26.00K | -$721.00K | -$818.00K | -$1.13M |
| Dividends paid | - | - | - |
PRECISION BIOSCIENCES INC reported operating cash flow of -$65.84M for fiscal year 2025. That is down 12.7% from -$58.45M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow declined from -$51.72M (FY 2018) to -$65.84M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $745.00K | $10.69M | $40.09M | $741.00K | $2.25M | $36.72M |